These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16034482)

  • 61. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
    François M; Richette P; Corvol MT
    Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis.
    von Knethen A; Soller M; Brüne B
    Arch Immunol Ther Exp (Warsz); 2007; 55(1):19-25. PubMed ID: 17277894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PPAR and Pain.
    Maeda T; Kishioka S
    Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.
    Varga T; Nagy L
    Eur J Clin Invest; 2008 Oct; 38(10):695-707. PubMed ID: 18837794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.
    Kaundal RK; Sharma SS
    Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Anti-atherosclerotic effects by PPARgamma and its ligands through the activation of reverse cholesterol transport system].
    Wakino S; Itoh H
    Nihon Rinsho; 2010 Feb; 68(2):217-23. PubMed ID: 20158087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response.
    Ren L; Konger RL
    Mol Carcinog; 2019 Sep; 58(9):1589-1601. PubMed ID: 31111568
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.
    Magri CJ; Gatt N; Xuereb RG; Fava S
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1279-94. PubMed ID: 21985541
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [PPARgamma as a new therapeutic target in inflammatory diseases].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.
    Giaginis C; Giagini A; Theocharis S
    Pharmacol Res; 2009 Sep; 60(3):160-9. PubMed ID: 19646655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.
    Straus DS; Glass CK
    Trends Immunol; 2007 Dec; 28(12):551-8. PubMed ID: 17981503
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [PPARgamma-gene therapy].
    Katayama K; Nakajima A
    Nihon Rinsho; 2010 Feb; 68(2):356-60. PubMed ID: 20158109
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.
    Villapol S
    Cell Mol Neurobiol; 2018 Jan; 38(1):121-132. PubMed ID: 28975471
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biology of PPAR gamma in cancer: a critical review on existing lacunae.
    Krishnan A; Nair SA; Pillai MR
    Curr Mol Med; 2007 Sep; 7(6):532-40. PubMed ID: 17896990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.